Risk Minimisation Materials

Xospata Healthcare Professional (HCP) Educational Information Brochure

This HCP Educational Information Brochure aims to provide information about Differentiation Syndrome related to XOSPATA (gilteritinib), to minimise the risk associated with this safety concern. The brochure contains the following: -Information on Xospata, including the approved indication according to the SmPC. -Description of the signs and symptoms of differentiation syndrome. -Management of differentiation syndrome

For Healthcare Professionals